Montemore Chewable LT-Antagonist
Montelukast sodium, is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene CysLT1 receptor, which is widely used for the prophylaxis and chronic treatment of asthma.
Montemore Chewable Montelukast as sodium 5mg
-
Adults
Aged 15 years and older
Indication
Dose
Dose
Asthma
10 mg
Once daily in evening
Symptomatic relief of seasonal allergic rhinitis
10 mg
Once daily in evening
Exercise-induced bronchoconstriction
10 mg
At least 2 hours before exercise
Seasonal allergic rhinitis (SAR)
10 mg
Once daily in evening
Paediatric
Aged 6 to 14 years
Indication
Dose
Dose
Asthma
5 mg
Once daily in evening
Symptomatic relief of seasonal allergic rhinitis
5 mg
Once daily in evening
Exercise-induced bronchoconstriction
5 mg
At least 2 hours before exercise
Seasonal allergic rhinitis (SAR)
5 mg
Once daily in evening
-
Hypersensitivity to any component of montelukast.